Literature DB >> 19288178

High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion.

Enrico Vizzardi1, Savina Nodari, Gregoriana Zanini, Alessandra Manerba, Silvia Frattini, Alberto Madureri, Riccardo Raddino, Livio Dei Cas.   

Abstract

Atrial fibrillation (AF) is often associated, more or less indirectly, with an inflammatory acute or chronic process. So it is probable that the inflammation could contribute to the genesis and the perpetuation of this dysrhythmia. Phlogistic test indexes in patients (pts) with AF will be positive and have prognostic significance in patients treated with electrical cardioversion with restoration of a sinus rhythm. We evaluated 106 pts affected by AF of recent onset without known cardiovascular disease. We measured the plasma concentration of C-reactive protein (CRP) through a high sensibility method, in addition to routine blood samples. We performed an ECG 1 week and a Holter ECG monitoring 1 and 6 months after the electrical cardioversion. The CRP values were high (5.8 +/- 10.7 U/L), with values above the normal range in 60 pts. After electrical cardioversion, we obtained restoration of sinus rhythm in all the patients. One week after cardioversion, 85 pts (80%) were in sinus rhythm, while after 6 months 60 pts (56%) maintained a sinus rhythm. In total 46 (43%) patients had a recurrence of atrial fibrillation within 6 months, and 41 of these 46 patients (89%) had elevated values of CRP (P < 0.001 with respect to the patients who maintained a sinus rhythm). 18/21 patients (86%) with an AF relapse in the first week and 23/25 patients (92%) with AF recurrences at 6 months later had elevated values of CRP. The patients with AF may have elevated values of CRP, and the assessment of this increase may be predictive of early relapses of AF after electrical cardioversion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288178     DOI: 10.1007/s11739-009-0235-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  23 in total

1.  Statins as potent antiinflammatory drugs.

Authors:  David J Lefer
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

2.  Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.

Authors:  Christopher J Boos; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

3.  Short-term effects of atorvastatin on C-reactive protein.

Authors:  W F Riesen; H Engler; M Risch; W Korte; G Noseda
Journal:  Eur Heart J       Date:  2002-05       Impact factor: 29.983

Review 4.  Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.

Authors:  Tonje A Aksnes; Arnljot Flaa; Arne Strand; Sverre E Kjeldsen
Journal:  J Hypertens       Date:  2007-01       Impact factor: 4.844

5.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.

Authors:  Giuseppe Patti; Massimo Chello; Dario Candura; Vincenzo Pasceri; Andrea D'Ambrosio; Elvio Covino; Germano Di Sciascio
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

7.  Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.

Authors:  P Bruins; H te Velthuis; A P Yazdanbakhsh; P G Jansen; F W van Hardevelt; E M de Beaumont; C R Wildevuur; L Eijsman; A Trouwborst; C E Hack
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

8.  Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials.

Authors:  Laurent Fauchier; Bertrand Pierre; Axel de Labriolle; Caroline Grimard; Noura Zannad; Dominique Babuty
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

9.  Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion.

Authors:  Chung-Wah Siu; Chu-Pak Lau; Hung-Fat Tse
Journal:  Am J Cardiol       Date:  2003-12-01       Impact factor: 2.778

10.  Inflammation as a risk factor for atrial fibrillation.

Authors:  Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

View more
  5 in total

1.  Mild inflammation may switch on again atrial fibrillation after successful electrical cardioversion.

Authors:  Filippo Marzot; Vittorio Pengo
Journal:  Intern Emerg Med       Date:  2009-06-09       Impact factor: 3.397

Review 2.  Inflammatory biomarkers and coronary heart disease: from bench to bedside and back.

Authors:  Gina Biasillo; Milena Leo; Roberta Della Bona; Luigi Marzio Biasucci
Journal:  Intern Emerg Med       Date:  2010-02-25       Impact factor: 3.397

3.  The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue.

Authors:  Licia Polimeni; Ludovica Perri; Mirella Saliola; Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2010-03-03       Impact factor: 3.397

4.  Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.

Authors:  Jelena Kornej; Borislav Dinov; Andrew D Blann; Sascha Rolf; Arash Arya; Josephine Schmidl; Daniela Husser; Gerhard Hindricks; Andreas Bollmann; Gregory Y H Lip
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

Review 5.  Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis.

Authors:  Alexander Weymann; Sadeq Ali-Hasan-Al-Saegh; Anton Sabashnikov; Aron-Frederik Popov; Seyed Jalil Mirhosseini; Tong Liu; Mohammadreza Lotfaliani; Michel Pompeu Barros de Oliveira Sá; William L L Baker; Senol Yavuz; Mohamed Zeriouh; Jae-Sik Jang; Hamidreza Dehghan; Lei Meng; Luca Testa; Fabrizio D'Ascenzo; Umberto Benedetto; Gary Tse; Luis Nombela-Franco; Pascal M Dohmen; Abhishek J Deshmukh; Cecilia Linde; Giuseppe Biondi-Zoccai; Gregg W Stone; Hugh Calkins; Integrated Meta-Analysis Of Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.